Campbell & Co. Investment Adviser »

Adma Biologics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.5M 232k 6.60
2023-09-30 $431k 120k 3.58

More positions owned by Campbell & Co. Investment Adviser

United Rentals Common Stock (URI)
Parker-Hannifin Corp Common Stock (PH)
TE Connectivity Common Stock (TEL)
Nov Common Stock (NOV)
Revvity Common Stock (RVTY)
DuPont de Nemours Common Stock (DD)
Credit Acceptance Corp Common Stock (CACC)
State Street Corp Common Stock (STT)
Franklin Resources Common Stock (BEN)
Chubb Common Stock (CB)
McKesson Corp Common Stock (MCK)
Cheniere Energy Common Stock (LNG)
Idacorp Common Stock (IDA)
Jack Henry & Associates Common Stock (JKHY)
Nordson Corp Common Stock (NDSN)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Adma Biologics

BlackRock
Vanguard Group
Nuveen Asset Management
American Century Companies
Perceptive Advisors
AWM Investment Company
D. E. Shaw & Co
Geode Capital Management
Two Sigma Investments
Morgan Stanley
Dimensional Fund Advisors
Two Sigma Advisers
Ophir Asset Management Pty
Assenagon Asset Management
Deutsche Bank Aktiengesellschaft

View all funds holding Adma Biologics